Texas HB 3086: Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

Status: Referred to Public Health (as of 2025-03-20)

State: Texas · Session: 89R · Bill: HB 3086

Subjects: HEALTH & HUMAN SERVICES COMMISSION (V0177), Health--General (I0385), Health--Other Diseases & Medical Conditions (I0383), MEDICINE & PRESCRIPTION DRUGS (S7338), Occupational Regulation--Health Occupations (I0540), STATE HEALTH SERVICES, DEPARTMENT OF (V0463)

Sponsors: Oliverson

View Texas HB 3086 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.